Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To clarify the clinicopathological features of breast cancer in young females, surveillance data of the Registration Committee of the Japanese Breast Cancer Society were analyzed.
The clinicopathological characteristics were compared between young (<35) patients and non-young (≥35) patients among 109,617 records registered between 2004 and 2009.
The numbers of young and non-young patients were 2,982 (2.7 %) and 106,295 (97.0 %), respectively. The young patients had more cases of a familial history of breast cancer, more subjective symptoms, fewer bilateral tumors, lower BMIs, larger tumors, more positive lymph nodes, fewer instances of an ER-positive status, more instances of an HER2-positive status, more triple-negative tumors and more advanced TNM stages. The young patients more frequently received neoadjuvant chemotherapy and breast-conserving therapy (BCT) compared with the non-young patients. Eighty percent of all patients received adjuvant therapy. The young patients were more frequently treated with chemotherapy, molecular targeted therapy and radiation therapy than the non-young patients.
In this study, young patients with breast cancer were diagnosed at more advanced stages and had more endocrine-unresponsive tumors than non-young patients. Further prognostic analyses should be conducted in this cohort.
- Matsuda, T, Marugame, T, Kamo, KI, Katanoda, K, Ajiki, W, Sobue, T (2012) Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42: pp. 139-147 CrossRef
- Anders, CK, Hsu, DS, Broadwater, G, Acharya, CR, Foekens, JA, Zhang, Y (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26: pp. 3324-3330 CrossRef
- Gonzalez-Angulo, AM, Broglio, K, Kau, SW, Eralp, Y, Erlichman, J, Valero, V (2005) Women age <35 years with primary breast carcinoma disease features at presentation. Cancer 103: pp. 2466-2472 CrossRef
- Ahn, SH, Son, BH, Kim, SW, Kim, SI, Jeong, J, Ko, SS (2007) Poor outcome of hormone receptor positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea-A report from the Korean Breast Cancer Society. J Clin Oncol 25: pp. 2360-2368 CrossRef
- Aebi, S, Gelber, S, Castiglione-Gertsch, M, Gelber, RD, Collins, J, Thürlimann, B (2000) Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?. Lancet 27: pp. 1869-1874 CrossRef
- Colleoni, M, Rotmensz, N, Robertson, C, Orlando, L, Viale, G, Renne, G (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13: pp. 273-279 CrossRef
- Pronzato P, Mustacchi G, DeMatteis A, Di Costanzo F, Rulli E, Floriani I, et al. Biological characteristics and medical treatment of breast cancer in young women—a featured population: results from the nora study. Int J Breast Cancer. 2011, Article ID 534256, doi:10.4061/2011/534256.
- Pagani, O, O’Neill, A, Castiglione, M (1998) Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer 34: pp. 632-640 CrossRef
- The Japanese breast cancer society. General roles for clinical and pathological recording of breast cancer.16th ed. Histological Classification of breast tumors. Tokyo: The Japanese breast cancer society; 2008. 18–59.
- World Health Organization histological typing of breast tumors. Am J Clin Pathol 78: pp. 806-816
- Harvey, JM, Clark, GM, Osborne, CK, Allred, DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: pp. 1474-1481
- Umemura, S, Kurosumi, M, Moriya, T, Oyama, T, Arihiro, K, Yamashita, H (2006) Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast cancer 13: pp. 232-235 CrossRef
- Leong, SP, Shen, ZZ, Liu, TJ, Agarwal, G, Tajima, T, Paik, NS (2010) Is breast cancer the same disease in Asian and Western Countries?. World J Surg 34: pp. 2308-2324 CrossRef
- Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012.
- Yoshimoto, M, Tada, K, Hori, H, Morota, A, Tanabe, M, Nishimura, S (2004) Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001-an institutional review. Jpn J Clin Oncol 34: pp. 457-462 CrossRef
- Saeki, T, Sano, M, Komoike, Y, Sonoo, H, Honjyo, H, Ochiai, K (2008) No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan. Int J Clin Oncol 13: pp. 8-11 CrossRef
- Sugano, K, Nakamura, S, Ando, J, Takayama, S, Kamata, H, Sekiguchi, I (2008) Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Sci 99: pp. 1967-1976 CrossRef
- Shi, YX, Xia, Q, Peng, RJ, Yuan, ZY, Wang, SS, An, X (2012) Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. J Cancer Res Clin Oncol 138: pp. 705-714 CrossRef
- Iwase, H, Kurebayashi, J, Tsuda, H, Ohta, T, Kurosumi, M, Miyamoto, K (2010) Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer 17: pp. 118-124 CrossRef
- Anders, CK, Fan, C, Parker, JS, Carey, LA, Blackwell, KL, Klauber-DeMore, N (2011) Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?. J Clin Oncol 29: pp. e18-e20 CrossRef
- Saji, S, Hiraoka, M, Tokuda, Y, Fukui, N, Ikeda, T (2012) Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004–2009. Breast Cancer 19: pp. 1-3 CrossRef
- Freedman, RA, Virgo, KS, Labadie, J, He, Y, Partridge, AH, Keating, NL (2012) Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat 135: pp. 893-906 CrossRef
- Buzdar, AU, Ibrahim, NK, Francis, D, Booser, DJ, Thomas, ES, Theriault, RL (2005) Significantly higher pathologic complete remissionrate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factorreceptor 2-positive operable breast cancer. J Clin Oncol 23: pp. 3676-3685 CrossRef
- Gianni, L, Dafni, U, Gelber, RD, Azambuja, E, Muehlbauer, S, Goldhirsch, A (2011) Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. Lancet Oncol 12: pp. 236-244 CrossRef
- Wong, M, O’Neill, S, Walsh, G, Smith, IE (2012) Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes. Ann Oncol.
- Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study
Volume 21, Issue 6 , pp 643-650
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Breast cancer in young females
- Surveillance data
- Industry Sectors
- Author Affiliations
- 1. Breast Surgery Clinic, 2nd Floor YCC-Takanawa Building, 2-21-43 Takanawa, Minato-ku, Tokyo, 108-0074, Japan
- 2. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- 3. Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan
- 4. Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan
- 5. Department of Nursing School of Health and Social Services, Saitama Prefectural University, Koshigaya, Saitama, Japan
- 6. Division of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan